https://www.yiliao.com/index.php?action=history&feed=atom&title=ADC_%E8%8D%AF%E7%89%A9
ADC 药物 - 版本历史
2026-04-21T10:44:43Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=ADC_%E8%8D%AF%E7%89%A9&diff=315013&oldid=prev
2026年1月20日 (二) 06:59 223.160.139.59
2026-01-20T06:59:43Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2026年1月20日 (二) 06:59的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3" >第3行：</td>
<td colspan="2" class="diff-lineno">第3行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="margin-bottom: 30px; border-bottom: 2px solid #000000; padding-bottom: 25px;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="margin-bottom: 30px; border-bottom: 2px solid #000000; padding-bottom: 25px;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <del class="diffchange diffchange-inline"><strong></del>[[ADC 药物]]<del class="diffchange diffchange-inline"></strong></del>（<del class="diffchange diffchange-inline"><strong></del>[[Antibody-Drug Conjugates]]**，抗体偶联药物）是一类通过化学连接子将具有高度特异性的 **[[单克隆抗体]]** 与高活性 **[[细胞毒性药物]]**（载荷）偶联而成的靶向生物制剂。其核心理念是将抗体的“定位”能力与化学药物的“杀伤”能力相结合，实现对肿瘤细胞的精准打击，同时降低对正常组织的损伤。**[[ADC]]** 的研发经历了三代更迭，目前已在 **[[乳腺癌]]**、**[[尿路上皮癌]]**、**[[血液恶性肿瘤]]** 等领域取得突破性进展，是 **[[肿瘤精准医疗]]** 的重要支柱。</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> [[ADC 药物]]（[[Antibody-Drug Conjugates]]**，抗体偶联药物）是一类通过化学连接子将具有高度特异性的 **[[单克隆抗体]]** 与高活性 **[[细胞毒性药物]]**（载荷）偶联而成的靶向生物制剂。其核心理念是将抗体的“定位”能力与化学药物的“杀伤”能力相结合，实现对肿瘤细胞的精准打击，同时降低对正常组织的损伤。**[[ADC]]** 的研发经历了三代更迭，目前已在 **[[乳腺癌]]**、**[[尿路上皮癌]]**、**[[血液恶性肿瘤]]** 等领域取得突破性进展，是 **[[肿瘤精准医疗]]** 的重要支柱。</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </p></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l118" >第118行：</td>
<td colspan="2" class="diff-lineno">第118行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="font-size: 0.9em; line-height: 1.7; color: #1e293b; margin-top: 50px; border-top: 2.5px solid #000000; padding-top: 25px; text-align: left;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="font-size: 0.9em; line-height: 1.7; color: #1e293b; margin-top: 50px; border-top: 2.5px solid #000000; padding-top: 25px; text-align: left;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <span style="color: #000000; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <span style="color: #000000; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline"> </del></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline"> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> [1] <strong>Drago JZ, et al. (2021).</strong> <em>Antibody-drug conjugates: the next generation of targeted cancer therapies.</em> <strong>[[Nature Reviews Clinical Oncology]]</strong>.<br></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> [1] <strong>Drago JZ, et al. (2021).</strong> <em>Antibody-drug conjugates: the next generation of targeted cancer therapies.</em> <strong>[[Nature Reviews Clinical Oncology]]</strong>.<br></div></td></tr>
</table>
223.160.139.59
https://www.yiliao.com/index.php?title=ADC_%E8%8D%AF%E7%89%A9&diff=315011&oldid=prev
223.160.139.59：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-20T06:58:00Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 2px solid #000000; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>[[ADC 药物]]</strong>（<strong>[[Antibody-Drug Conjugates]]**，抗体偶联药物）是一类通过化学连接子将具有高度特异性的 **[[单克隆抗体]]** 与高活性 **[[细胞毒性药物]]**（载荷）偶联而成的靶向生物制剂。其核心理念是将抗体的“定位”能力与化学药物的“杀伤”能力相结合，实现对肿瘤细胞的精准打击，同时降低对正常组织的损伤。**[[ADC]]** 的研发经历了三代更迭，目前已在 **[[乳腺癌]]**、**[[尿路上皮癌]]**、**[[血液恶性肿瘤]]** 等领域取得突破性进展，是 **[[肿瘤精准医疗]]** 的重要支柱。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 320px; float: right; margin: 0 0 25px 25px; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">ADC 药物 (抗体偶联)</div><br />
<div style="font-size: 0.75em; opacity: 0.85; margin-top: 4px;">Antibody-Drug Conjugates · 点击展开</div><br />
</div><br />
<br />
<div class="mw-collapsible-content" style="display: none;"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="padding: 10px; border: 1px solid #e2e8f0; border-radius: 8px; background: #fff; display: inline-block;"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px;">[[Targeted]] [[Therapy]] [[Icon]]</div><br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">核心参数 (以典型 HER2-ADC 为例)</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 45%;">常见靶点</th><br />
<td style="padding: 10px 12px; border-bottom: 1px solid #e2e8f0;">[[HER2]], [[TROP2]], [[CD30]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[Entrez ID]] (Target)</th><br />
<td style="padding: 10px 12px; border-bottom: 1px solid #e2e8f0;">2064 (ERBB2)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[HGNC ID]] (Target)</th><br />
<td style="padding: 10px 12px; border-bottom: 1px solid #e2e8f0;">3430</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[UniProt ID]] (Target)</th><br />
<td style="padding: 10px 12px; border-bottom: 1px solid #e2e8f0;">P04626</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">典型 [[DAR]]</th><br />
<td style="padding: 10px 12px; border-bottom: 1px solid #e2e8f0;">3.5 - 8.0</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 10px 12px; background-color: #f1f5f9; color: #475569;">关键载荷类型</th><br />
<td style="padding: 10px 12px;">[[MMAE]], [[DXd]], [[SN-38]]</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #000000; padding: 10px 18px; border-radius: 0 4px 4px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #000000; font-weight: bold;">核心机制：ADC 的特洛伊木马杀伤路径</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
<strong>[[ADC]]</strong> 的杀伤过程分为多个步骤，其成功取决于受体识别与载荷释放的精准衔接：<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>循环与结合：</strong> ADC 进入血液循环后，抗体部分特异性结合肿瘤细胞表面的靶抗原（如 <strong>[[HER2]]</strong> 或 <strong>[[TROP2]]</strong>）。</li><br />
<li style="margin-bottom: 12px;"><strong>内吞与运输：</strong> 抗原-ADC 复合物通过 <strong>[[受体介导的内吞作用]]</strong> 进入胞内，形成早期 <strong>[[内体]]</strong>。</li><br />
<li style="margin-bottom: 12px;"><strong>溶酶体降解：</strong> 复合体转运至 <strong>[[溶酶体]]</strong>。在酸性环境或 <strong>[[组织蛋白酶]]</strong> 的作用下，<strong>[[连接子]]</strong> 被切断，释放出活性细胞毒性载荷。</li><br />
<li style="margin-bottom: 12px;"><strong>旁观者效应 (Bystander Effect)：</strong> 释放出的疏水性载荷可以穿透细胞膜，杀伤邻近不表达靶抗原的肿瘤细胞，从而克服肿瘤的 <strong>[[异质性]]</strong>。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #000000; padding: 10px 18px; border-radius: 0 4px 4px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #000000; font-weight: bold;">临床矩阵：全球主要已获批 ADC 药物特征</h2><br />
<div style="overflow-x: auto; margin: 30px auto;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #000000;"><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; width: 22%;">药物名称 (通用名)</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1;">靶点 (Target)</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1;">载荷 (Payload)</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1;">核心优势</th><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[德曲妥珠单抗]] (DS-8201)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[HER2]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">DXd (拓扑异构酶I抑制剂)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">高 DAR (8.0)，极强旁观者效应。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[恩美曲珠单抗]] (T-DM1)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[HER2]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">DM1 (微管蛋白抑制剂)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">安全性良好，辅助治疗标准。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[戈沙妥珠单抗]] (SG)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[TROP2]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">SN-38</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">突破三阴性乳腺癌后线治疗。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[维布妥昔单抗]] (BV)</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[CD30]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">MMAE</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[霍奇金淋巴瘤]]治疗基石。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #000000; padding: 10px 18px; border-radius: 0 4px 4px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #000000; font-weight: bold;">治疗策略：从结构设计到临床管理</h2><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>DAR (药物抗体比) 优化：</strong> 现代 ADC 倾向于更均一且更高（如 DAR 8.0）的载荷负载，以提高低抗原表达细胞的杀伤力。</li><br />
<li style="margin-bottom: 12px;"><strong>克服耐药：</strong> 通过切换不同机制的载荷（如从微管抑制剂切换为拓扑异构酶抑制剂），可以克服前线治疗产生的 <strong>[[获得性耐药]]</strong>。</li><br />
<li style="margin-bottom: 12px;"><strong>特异性毒性管理：</strong> ADC 具有独特的 <strong>[[脱靶毒性]]</strong>。例如，含 DXd 的药物需警惕 <strong>[[间质性肺疾病]]</strong>（ILD），而 TROP2-ADC 需管理 <strong>[[腹泻]]</strong> 和骨髓抑制。</li><br />
</ul><br />
<br />
<div style="margin: 40px 0; border: 1.2px solid #e2e8f0; border-radius: 10px; padding: 25px; background-color: #ffffff;"><br />
<h3 style="margin-top: 0; color: #000000; font-size: 1.15em; margin-bottom: 20px; border-bottom: 2px solid #000000; display: inline-block; padding-bottom: 5px;">关键相关概念</h3><br />
<div style="display: flex; flex-direction: column; gap: 12px; font-size: 0.95em;"><br />
<div style="color: #334155;"><strong style="color: #1e40af;">[[DAR]]</strong>：Drug-to-Antibody Ratio，衡量每个抗体分子平均挂载药量的核心指标。</div><br />
<div style="color: #334155;"><strong style="color: #1e40af;">[[旁观者效应]]</strong>：指 ADC 载荷透过膜杀伤周围“无辜”或低表达癌细胞的现象。</div><br />
<div style="color: #334155;"><strong style="color: #1e40af;">[[不可切割连接子]]</strong>：依赖溶酶体蛋白酶降解抗体本身释放药物，稳定性更高，通常旁观者效应较弱。</div><br />
<div style="color: #334155;"><strong style="color: #1e40af;">[[HER2-low]]</strong>：受 ADC（如 DS-8201）影响而新定义的临床获益亚型。</div><br />
</div><br />
</div><br />
<br />
<div style="font-size: 0.9em; line-height: 1.7; color: #1e293b; margin-top: 50px; border-top: 2.5px solid #000000; padding-top: 25px; text-align: left;"><br />
<span style="color: #000000; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Drago JZ, et al. (2021).</strong> <em>Antibody-drug conjugates: the next generation of targeted cancer therapies.</em> <strong>[[Nature Reviews Clinical Oncology]]</strong>.<br><br />
<span style="color: #475569;">[学术点评]：[Academic Review] 该综述系统界定了新一代 ADC 在克服异质性和增强载荷释放方面的进化。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Chau CH, et al. (2019).</strong> <em>Antibody-drug conjugates for cancer.</em> <strong>[[The Lancet]]</strong>.<br><br />
<span style="color: #475569;">[学术点评]：详述了 ADC 的三要素设计如何影响药物的药代动力学及临床安全性。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #f1f5f9; color: #334155; padding: 8px 15px; font-weight: bold; text-align: left; border-bottom: 1px solid #e2e8f0;"><br />
ADC 药物体系 · 知识图谱导航<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 100px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 15px; text-align: left; vertical-align: middle;">核心组件</td><br />
<td style="padding: 10px 15px; color: #334155; text-align: left;">[[单克隆抗体]] • [[连接子 Linker]] • [[细胞毒性载荷 Payload]] • [[糖基化修饰]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 100px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 15px; text-align: left; vertical-align: middle;">关键机制</td><br />
<td style="padding: 10px 15px; color: #334155; text-align: left;">[[内吞作用]] • [[溶酶体降解]] • [[旁观者效应]] • [[DNA 损伤]] • [[微管抑制]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 100px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 15px; text-align: left; vertical-align: middle;">临床标杆</td><br />
<td style="padding: 10px 15px; color: #334155; text-align: left;">[[DS-8201]] • [[Enhertu]] • [[Kadcyla]] • [[Trodelvy]] • [[Adcetris]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
223.160.139.59